VEGF gene therapy for coronary artery disease and peripheral vascular disease (Q35109285)

6 August 2017

1 reference

title

VEGF gene therapy for coronary artery disease and peripheral vascular disease (English)

1 reference

6 August 2017

0 references

coronary artery disease

1 reference

inferred from title

author name string

Henrik Sandvad Rasmussen

series ordinal

1 reference

6 August 2017

Camilla Sandvad Rasmussen

series ordinal

1 reference

6 August 2017

Jennifer Macko

series ordinal

1 reference

6 August 2017

publication date

1 April 2002

1 reference

Cardiovascular radiation medicine

6 August 2017

published in

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

114-117

1 reference

Utilization of coronary angiography and revascularization after acute myocardial infarction in men and women risk stratified by the American College of Cardiology/American Heart Association guidelines

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft [...]

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

The prevalence of peripheral arterial disease in a defined population

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

The epidemiology of peripheral arterial disease: importance of identifying the population at risk

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

A review of the literature: transmyocardial laser revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Molecular and biological properties of the vascular endothelial growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Adenovirus-mediated in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Therapeutic angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1522-1865%2802%2900158-0

7 January 2021

10.1016/S1522-1865(02)00158-0

Identifiers

DOI

1 reference

6 August 2017

1 reference